Crescent Sterling’s Merck MRK Stock Holding History

Crescent Sterling’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$706K	Sell	5,497 -22	-0.4%	-$2.58K	0.63%	45
2026 Q1	$664K	Buy	5,519 +304	+6%	+$35.1K	0.64%	44
2025 Q4	$549K	Sell	5,215 -36	-0.7%	-$3.38K	0.56%	46
2025 Q3	$441K	Sell	5,251 -565	-10%	-$46.5K	0.46%	54
2025 Q2	$460K	Sell	5,816 -595	-9%	-$47.3K	0.52%	48
2025 Q1	$575K	Sell	6,411 -97	-1%	-$9.06K	0.59%	48
2024 Q4	$647K	Sell	6,508 -513	-7%	-$52.9K	0.66%	44
2024 Q3	$797K	Sell	7,021 -69	-1%	-$8.2K	0.76%	39
2024 Q2	$878K	Sell	7,090 -171	-2%	-$22K	0.84%	36
2024 Q1	$958K	Sell	7,261 -20	-0.3%	-$2.46K	0.87%	35
2023 Q4	$794K	Sell	7,281 -610	-8%	-$63.3K	0.79%	37
2023 Q3	$812K	Buy	7,891 +660	+9%	+$71.1K	0.86%	36
2023 Q2	$834K	Sell	7,231 -3	-0%	-$341	0.79%	38
2023 Q1	$770K	Sell	7,234 -33	-0.5%	-$3.56K	0.75%	39
2022 Q4	$806K	Buy	+7,267	New	+$743K	0.87%	36

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Crescent Sterling's MRK Position: Q2 2026 in Review

Crescent Sterling reduced its Merck (MRK) stake by 0.4% in Q2 2026, selling an estimated $2.58K and leaving 5,497 shares worth $706K. The position accounts for 0.63% of the portfolio, ranked #45.

Crescent Sterling first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $958K in Q1 2024. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Crescent Sterling held 5,497 shares of Merck worth $706K as of Q2 2026.
Crescent Sterling sold 22 Merck shares in Q2 2026, an estimated $2.58K.
Merck made up 0.63% of Crescent Sterling's portfolio in Q2 2026, its #45 holding.
Crescent Sterling first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
Crescent Sterling's Merck position peaked at $958K in Q1 2024.
1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.